Tyrolean Biotech Company Cyprumed Closes 493 Million Dollar Deal with American MSD
The Innsbruck-based biotechnology company Cyprumed GmbH is making international headlines with a multi-million dollar license deal: Together with the U.S.…
Den ganzen Artikel lesen: Tyrolean Biotech Company Cyprumed Closes 493 Mi [...]
The Innsbruck-based biotechnology Company Cyprumed GmbH with a
with the U.S.--
Tyrolean Biotech Company Cyprumed Closes
Quelle:
vindobona.org
Zeitstempel:
2025-05-05
01:40